Interventions for Tuberculosis Control and Elimination 2002
Interventions for Tuberculosis Control and Elimination 2002
Interventions for Tuberculosis Control and Elimination 2002
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
230. Morgan JR, Clarke KW, Brear SG. Phenomenon of rifampicin-induced discolouration<br />
of body fluids. (Correspondence). Respir Med 1993; 84: 320-1.<br />
231. Lyons RW. Orange contact lenses from rifampin. (Correspondence). N Engl<br />
J Med 1979; 300: 372-3.<br />
232. Poitrineau Y, Barthelemy J, Rouby D, Fauron P, Barrau P, Beligon C. Intoxication<br />
mortelle par la rifampicine.<br />
271-3.<br />
A propos d’une observation. Therapie 1993; 48:<br />
233. Holdiness MR. Rifampicin adverse cutaneous reaction. (Correspondence). Int<br />
J Dermatol 1986; 25: 72-3.<br />
234. Bolan G, Laurie RE, Broome CV. Red man syndrome: inadvertent administration<br />
of an excessive dose of rifampin to children in a day-care center.<br />
1986; 77:633-5.<br />
Pediatrics<br />
235. Damkier P, Hansen LL, Brøsen K. Rifampicin treatment greatly increases the<br />
apparent oral clearance of quinidine. Pharmacol Toxicol 1999; 85: 257-62.<br />
236. Raghupati Sarma G, Acharyulu GS, Kannapiran M, Krishna Murthy PV,<br />
Gurumurthy P, Tripathy SP. Role of rifampicin in arthralgia induced by pyrazinamide.<br />
Tubercle 1983; 64: 93-100.<br />
237. Baciewicz AM, Self TH.<br />
144: 1667-71.<br />
Rifampin drug interactions. Arch Intern Med 1984;<br />
238. Acocella G, Conti R.<br />
61: 171-7.<br />
Interaction of rifampicin with other drugs. Tubercle 1980;<br />
239. Baciewicz AM, Self TH, Bekemeyer WB.<br />
Arch Intern Med 1987; 147: 565-8.<br />
Update on rifampin drug interactions.<br />
240. Strayhorn VA, Baciewicz AM, Self TH. Update on rifampin drug interactions,<br />
III. Arch Intern Med 1997; 157: 2453-8.<br />
241. Bhatia RS, Uppal R, Malhi R, Behera D, Jindal SK. Drug interaction between<br />
rifampicin <strong>and</strong> cotrimoxazole in patients with tuberculosis.<br />
1991; 10: 419-21.<br />
Hum Exp Toxicol<br />
242. Jaruratanasirikul S, Sriwiriyajan S. Effect of indinavir on the pharmacokinetics<br />
of rifampicin in HIV-infected patients. Pharm Pharmacol 2001; 53: 409-12.<br />
243. Twum-Barima Y, Carruthers SG.<br />
1981; 304: 1466-9.<br />
Quinidine-rifampin interaction. N Engl J Med<br />
244. Bussey HL, Merritt GJ, Hill EG. The influence of rifampin on quinidine <strong>and</strong><br />
digoxin. Arch Intern Med 1984; 144: 1021-3.<br />
245. Mauro VF, Somani P, Temesy-Armos PN. Drug interaction between lorcainide<br />
<strong>and</strong> rifampicin. Eur J Clin Pharmacol 1987; 31: 737-8.<br />
246. Hauser AR, Lee C, Teague RB, Mullins C. The effect of rifampin on theophylline<br />
disposition. (Abstract). Clin Pharmacol Ther 1983; 33: 254.<br />
247. Straughn AB, Henderson RP, Lieberman PL, Self TH. Effect of rifampin on<br />
theophylline disposition. Therapeutic Drug Monitoring 1984; 6: 153-6.<br />
185